Ota Financial Group L.P. Invitae Corp Transaction History

Ota Financial Group L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$6.28 - $15.59 $204,728 - $508,234	-32,600 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$26.09 - $40.4 $780,091 - $1.21 Million	-29,900 Reduced 47.84%	32,600 $1.1 Million
Q1 2021 Apr 14, 2021	BUY	$33.06 - $56.93 $2.07 Million - $3.56 Million	62,500 New	62,500 $2.39 Million
Q3 2020 Oct 28, 2020	SELL	$28.43 - $44.67 $366,093 - $575,215	-12,877 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$11.71 - $30.29 $56,208 - $145,392	-4,800 Reduced 27.15%	12,877 $390,000

Q1 2020 Apr 16, 2020	BUY	$7.64 - $27.5 $135,052 - $486,117	17,677 New	17,677 $241,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Ota Financial Group L.P., based on Form 13F filings with the SEC.

Stay updated on Ota Financial Group L.P. with notifications on news.